Partner Content Partner Content Juergen Knoebel from Roche speaks at the High Potent Medicin... Insights on HPAPI manufacturing
Events Partner Content The High Potent Medicines Conference The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.